A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
Food companies are rushing to reformulate products for protein lovers. That’s a category that includes both people taking the powerful new class of obesity drugs known as GLP-1s, who are ...
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
Pharmaceutical giant Novo Nordisk (NYSE: NVO) released its fourth-quarter and full-year earnings report on Feb. 5. Here are two important insights from that call that should excite investors about ...
4don MSN
There’s no direct link between vision loss and taking the weight loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, ...
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...
Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...
4h
MarketBeat on MSNNovo Nordisk Shares Near New 52-Week Low: Analysts See Big UpsideShares of weight loss and diabetes medication maker Novo Nordisk (NYSE: NVO) have slumped precipitously over the past 52 ...
People taking weight-loss drugs say they are losing their sight. Science is trying to figure out why
Several patients using brand-name drugs like Ozempic, Wegovy, Mounjaro, and Zepbound experienced problems with their eyes, researchers said. Seven of the nine patients their study focused on had a ...
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several people who developed eye conditions soon after they began taking semaglutide ...
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results